6-50823871-CACAAACAAACAA-CACAAACAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003221.4(TFAP2B):c.540+28_540+31delCAAA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 1,537,964 control chromosomes in the GnomAD database, including 116,547 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.47 ( 18763 hom., cov: 0)
Exomes 𝑓: 0.37 ( 97784 hom. )
Consequence
TFAP2B
NM_003221.4 intron
NM_003221.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.31
Genes affected
TFAP2B (HGNC:11743): (transcription factor AP-2 beta) This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-50823871-CACAA-C is Benign according to our data. Variant chr6-50823871-CACAA-C is described in ClinVar as [Benign]. Clinvar id is 258985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-50823871-CACAA-C is described in Lovd as [Likely_benign]. Variant chr6-50823871-CACAA-C is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFAP2B | NM_003221.4 | c.540+28_540+31delCAAA | intron_variant | ENST00000393655.4 | NP_003212.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFAP2B | ENST00000393655.4 | c.540+28_540+31delCAAA | intron_variant | 1 | NM_003221.4 | ENSP00000377265.2 | ||||
TFAP2B | ENST00000344788.7 | c.534+28_534+31delCAAA | intron_variant | 3 | ENSP00000342252.3 | |||||
TFAP2B | ENST00000489228.1 | n.*7_*10delACAA | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.470 AC: 71100AN: 151176Hom.: 18724 Cov.: 0
GnomAD3 genomes
AF:
AC:
71100
AN:
151176
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.377 AC: 51128AN: 135480Hom.: 10407 AF XY: 0.381 AC XY: 28134AN XY: 73818
GnomAD3 exomes
AF:
AC:
51128
AN:
135480
Hom.:
AF XY:
AC XY:
28134
AN XY:
73818
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.369 AC: 511676AN: 1386672Hom.: 97784 AF XY: 0.370 AC XY: 253409AN XY: 684686
GnomAD4 exome
AF:
AC:
511676
AN:
1386672
Hom.:
AF XY:
AC XY:
253409
AN XY:
684686
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.471 AC: 71195AN: 151292Hom.: 18763 Cov.: 0 AF XY: 0.469 AC XY: 34652AN XY: 73856
GnomAD4 genome
AF:
AC:
71195
AN:
151292
Hom.:
Cov.:
0
AF XY:
AC XY:
34652
AN XY:
73856
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Char syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at